BR0312917A - Novos compostos gem difluorados, seus processos de preparo e suas respectivas aplicações - Google Patents
Novos compostos gem difluorados, seus processos de preparo e suas respectivas aplicaçõesInfo
- Publication number
- BR0312917A BR0312917A BR0312917-9A BR0312917A BR0312917A BR 0312917 A BR0312917 A BR 0312917A BR 0312917 A BR0312917 A BR 0312917A BR 0312917 A BR0312917 A BR 0312917A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- compounds
- applications
- new
- preparation processes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000002360 preparation method Methods 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 abstract 2
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical compound C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 abstract 2
- DVFXLNFDWATPMW-IWOKLKJTSA-N tert-butyldiphenylsilyl Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO[Si](C=2C=CC=CC=2)(C=2C=CC=CC=2)C(C)(C)C)[C@@H](OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](CC(O2)N2C3=NC=NC(N)=C3N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)O)C1 DVFXLNFDWATPMW-IWOKLKJTSA-N 0.000 abstract 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical class NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000003158 alcohol group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"NOVOS COMPOSTOS GEM DIFLUORADOS, SEUS PROCESSOS DE PREPARO E SUAS RESPECTIVAS APLICAçõES". O produto, de acordo com a invenção, se refere a um composto gem difluorado de fórmula (I), no qual R^ 1^ é um grupamento que comporta uma cadeia alquila substituída por pelo menos uma função amina, amida ou ácida; R^ 2^ é um átomo; R^ 3^ de hidrogênio H ou uma função álcool livre ou protegida; R^ 3^é um grupamento H, CH~ 3~, CH~ 2~OH, CH~2~-OGP no qual GP é um grupo protetor, tal como um grupo alquila, benzila (Bn), trimetilsilila (TMS), terc-butildimetilsilila (TBDMS), terc-butildifenilsilila (TBDPS), acetato (Ac) .... Y, Y<39>, Y<39><39> são grupos independentes, nos quais Y, Y<39>, Y<39><39>= H, OR, N~3~, NR<39>R<39><39>, SR<39><39> <39> ... com R H, Bn, Ac, TMS, TBDMS, TBDPS, .... R<39>, R<39><39>= H, alquil, alil, Bn, tosilato (Ts) , C(=O)-alquil, C(=O)-Bn, ... 1 R<39><39> <39>= H, alquil, Ac. Ela se aplica notadamente à utilização desse composto para o preparo de medicamentos antitumorais, antivirais, hipoglicemiantes, anti-inflamatórios e de compostos para a imunologia, a cosmetologia, ou ainda de análogos glicopeptídicos de moléculas antigel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0209627A FR2842810B1 (fr) | 2002-07-25 | 2002-07-25 | Nouveaux composes gem difluores, leur procedes de preparation et leurs applications. |
| PCT/FR2003/002330 WO2004014928A2 (fr) | 2002-07-25 | 2003-07-23 | Nouveaux composes gem difluores, leurs procedes de preparation et leurs applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0312917A true BR0312917A (pt) | 2005-07-05 |
Family
ID=30011584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0312917-9A BR0312917A (pt) | 2002-07-25 | 2003-07-23 | Novos compostos gem difluorados, seus processos de preparo e suas respectivas aplicações |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060142206A1 (pt) |
| EP (1) | EP1525208A2 (pt) |
| JP (1) | JP2006508048A (pt) |
| CN (1) | CN1671723A (pt) |
| AU (1) | AU2003274202A1 (pt) |
| BR (1) | BR0312917A (pt) |
| CA (1) | CA2492940A1 (pt) |
| FR (1) | FR2842810B1 (pt) |
| RU (1) | RU2369612C2 (pt) |
| TN (1) | TNSN05017A1 (pt) |
| WO (1) | WO2004014928A2 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2878851B1 (fr) * | 2004-12-02 | 2007-02-09 | Inst Nat Sciences Appliq | Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation |
| FR2900406B1 (fr) * | 2006-04-27 | 2013-09-06 | Inst Nat Sciences Appliq | Mimes stables de sucres de type c-glycosides et c-glycoconjugues,leur procede de preparation et leurs applications notamment dans le domaine de la cosmetique et du medicament. |
| FR2900405B1 (fr) * | 2006-04-27 | 2013-11-29 | Inst Nat Sciences Appliq | Nouveaux composes c-glycosides monofluores, leurs procedes de preparation et leurs applications |
| FR2900656A1 (fr) * | 2006-05-03 | 2007-11-09 | Inst Nat Sciences Appliq | Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation notamment pour la preservation de materiaux biologiques |
| US20100068692A1 (en) * | 2008-02-07 | 2010-03-18 | University Of Ottawa | Antifreeze glycoprotein analogues and uses thereof |
| FR2929615B1 (fr) | 2008-04-02 | 2010-12-17 | Tfchem | Composes c-aryl glycosides pour le traitement du diabete et de l'obesite. |
| KR100931249B1 (ko) * | 2008-06-05 | 2009-12-11 | 주식회사 알앤엘바이오 | 신규 디아릴 헵타노이드계 화합물 및 그 용도 |
| WO2012016935A1 (en) | 2010-08-02 | 2012-02-09 | Centrum Für Angewandte Nanotechnologie (Can) Gmbh | Seven carbon (c-7) sugars derivatives and their use |
| BR112013015869A2 (pt) | 2010-12-22 | 2017-07-04 | Tfchem | composto, processo para preparar um composto, uso, peptídeo e composição farmacêutica ou cosmética. |
| WO2013021018A1 (en) | 2011-08-08 | 2013-02-14 | Tfchem | Gem-difluorinated c-isopropylgalactoside derivates |
| CN103497223B (zh) * | 2013-09-13 | 2015-08-05 | 中国人民解放军第二军医大学 | 一种北沙参中所含的糖苷类化合物及其制备方法和应用 |
| CA2942731C (en) | 2014-03-17 | 2022-11-22 | Tfchem | Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0354323A3 (en) * | 1988-08-12 | 1990-06-13 | American Cyanamid Company | Antidiabetic phosphates |
| WO1994003480A1 (en) * | 1992-07-31 | 1994-02-17 | Pfizer Inc. | Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents |
| GB9723589D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
| DE60010913T2 (de) * | 1999-10-15 | 2005-06-09 | Sucampo Ag | Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung |
-
2002
- 2002-07-25 FR FR0209627A patent/FR2842810B1/fr not_active Expired - Fee Related
-
2003
- 2003-07-23 CA CA002492940A patent/CA2492940A1/fr not_active Abandoned
- 2003-07-23 CN CNA038177706A patent/CN1671723A/zh active Pending
- 2003-07-23 BR BR0312917-9A patent/BR0312917A/pt not_active IP Right Cessation
- 2003-07-23 AU AU2003274202A patent/AU2003274202A1/en not_active Abandoned
- 2003-07-23 JP JP2004526949A patent/JP2006508048A/ja active Pending
- 2003-07-23 EP EP03758183A patent/EP1525208A2/fr not_active Withdrawn
- 2003-07-23 WO PCT/FR2003/002330 patent/WO2004014928A2/fr active Application Filing
- 2003-07-23 US US10/522,365 patent/US20060142206A1/en not_active Abandoned
- 2003-07-23 RU RU2005105066/04A patent/RU2369612C2/ru not_active IP Right Cessation
-
2005
- 2005-01-24 TN TNP2005000017A patent/TNSN05017A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006508048A (ja) | 2006-03-09 |
| AU2003274202A1 (en) | 2004-02-25 |
| AU2003274202A8 (en) | 2004-02-25 |
| TNSN05017A1 (fr) | 2007-05-14 |
| EP1525208A2 (fr) | 2005-04-27 |
| CA2492940A1 (fr) | 2004-02-19 |
| WO2004014928A2 (fr) | 2004-02-19 |
| RU2005105066A (ru) | 2005-08-27 |
| FR2842810B1 (fr) | 2006-01-27 |
| FR2842810A1 (fr) | 2004-01-30 |
| WO2004014928A3 (fr) | 2004-04-01 |
| RU2369612C2 (ru) | 2009-10-10 |
| US20060142206A1 (en) | 2006-06-29 |
| CN1671723A (zh) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0312917A (pt) | Novos compostos gem difluorados, seus processos de preparo e suas respectivas aplicações | |
| KR960034164A (ko) | 스틸벤 유도체 및 이를 함유하는 약제학적 조성물 | |
| BR0308261A (pt) | Métodos extrativos para puruficação de sucralose | |
| UY28374A1 (es) | Agentes terapéuticos | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
| BR0114253A (pt) | Antagonistas de receptor de glutamato metabotrópico | |
| WO2009018955A3 (de) | Zusammensetzungen enthaltend diethanolaminesterquats | |
| MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
| MY149180A (en) | Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof | |
| BRPI0519557A2 (pt) | composto fluoroquÍmico, composiÇço de revestimento, artigo, e, mÉtodo para fabricar um composto fluoroquÍmico | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| BRPI0809981A2 (pt) | Compostos, processo de fabricação destes, composição farmacêutica que os contém, método de tratamento e/ou prevenção de doenças que são associadas a modulação de receptores de sst subtipo 5 e uso dos compostos. | |
| MA35886B1 (fr) | Dérivés de benzylsulfanilamide utilisés comme inhibiteurs -2 mogat | |
| CY1118131T1 (el) | Φαρμακο δραστικο στο νευροπαθητικο αλγος | |
| BRPI0508232A (pt) | sìntese de epotilonas, intermediários das mesmas, análogos e usos das mesmas | |
| BR0111290A (pt) | Misturas de estabilizantes | |
| GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing | |
| WO2010002528A3 (en) | Hydrofluoroacetal compounds and processes for their preparation and use | |
| MY158069A (en) | Tricyclic compound and pharmaceutical use thereof | |
| HUP0302758A2 (hu) | Eljárás jopamidol előállítására és az eljárásnál alkalmazásra kerülő új intermedierek | |
| AR035375A1 (es) | Compuesto derivado de pirrol sustituido, composicion farmaceutica y su uso en la fabricacion de un medicamento para inhibir la farnesiltransferasa | |
| IN2015DN02337A (pt) | ||
| MX9203928A (es) | Mono y bis alquilamino-antraciclinas y procedimiento para su preparacion. | |
| BRPI0518998A2 (pt) | âmega-feniloctanamidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |